Latest Articles

Publication Date
A Risk-Stratified Model for Predicting Endometrial Atypical Hyperplasia and Cancer to Guide Biopsy Decisions in Asymptomatic Postmenopausal Women - Frontiers

A Risk-Stratified Model for Predicting Endometrial Atypical Hyperplasia and Cancer to Guide Biopsy Decisions in Asymptomatic Postmenopausal Women Frontiers

Published: Nov. 24, 2025, 8:22 p.m.
HAS Renews Early Access for Jemperli in Advanced Endometrial Cancer - NAVLIN DAILY

HAS Renews Early Access for Jemperli in Advanced Endometrial Cancer NAVLIN DAILY

Published: Nov. 24, 2025, 12:18 p.m.
Is sub-endometrial injection a superior method for the administration of intrauterine PRP?: a systematic review and meta-analysis - Reproductive Biology and Endocrinology

Is sub-endometrial injection a superior method for the administration of intrauterine PRP?: a systematic review and meta-analysis Reproductive Biology and Endocrinology

Published: Nov. 24, 2025, 11:46 a.m.
Mesonephric-like Adenocarcinoma (MLA) Diagnostic Criteria and Controversies: Perspectives and Guidance From Pathologists in the MLA Consortium.

Mesonephric-like adenocarcinoma (MLA) is a rare and aggressive gynecologic malignancy that has only been recognized in the last decade. It arises in the endometrium, ovaries, and other extrauterine sites (often …

Published: Nov. 24, 2025, midnight
Single-cell and spatially resolved omics reveal transcriptional and metabolic signatures of ovarian endometriomas.

Endometriosis involves ectopic growth of endometrial-like tissue, yet the spatial transcriptomic and metabolic landscape of ovarian endometriomas remains poorly understood. This investigation presents a comprehensive multi-omics analysis of ovarian endometriomas …

Published: Nov. 22, 2025, midnight
Vivek Podder: Future Directions for ICI Rechallenge in Advanced Endometrial Cancer - Oncodaily

Vivek Podder: Future Directions for ICI Rechallenge in Advanced Endometrial Cancer Oncodaily

Published: Nov. 21, 2025, 4:19 p.m.
GSK preps lawsuit against US firm AnaptysBioover endometrial cancer drug - This is Money

GSK preps lawsuit against US firm AnaptysBioover endometrial cancer drug This is Money

Published: Nov. 21, 2025, 11:48 a.m.
Metabolomics reveals the therapeutic efficacy of liposomal resvida in endometrial cancer through regulating autophagy-related gene expression - springermedicine.com

Metabolomics reveals the therapeutic efficacy of liposomal resvida in endometrial cancer through regulating autophagy-related gene expression springermedicine.com

Published: Nov. 21, 2025, 2:26 a.m.
What Is the Role of ctDNA in Ovarian and Endometrial Cancers? - ASCO Daily News

What Is the Role of ctDNA in Ovarian and Endometrial Cancers? ASCO Daily News

Published: Nov. 21, 2025, 2:24 a.m.
Acute Cerebellitis Due to Administration of Durvalumab for Recurrent Endometrial Cancer: A Case Report - Cureus

Acute Cerebellitis Due to Administration of Durvalumab for Recurrent Endometrial Cancer: A Case Report Cureus

Published: Nov. 21, 2025, 1:57 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!